Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [ 177 Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
Journal of Nuclear Medicine · 2025
DOI: 10.2967/jnumed.124.269252 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Louise Kostos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; louise.kostos@petermac.org. Hauptthemen laut MEDLINE: Dipeptides, Heterocyclic Compounds, 1-Ring, Lutetium, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; louise.kostos@petermac.org.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Radiopharmaceutical Production and Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Zitieren
APA
Kostos, L., Buteau, J. P., Kong, G., Tran, B., Haskali, M. B., Fahey, M., Crumbaker, M., Emmett, L., Hofman, M. S., & Azad, A. A. (2025). Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [ 177 Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.269252
Vancouver
Kostos L, Buteau JP, Kong G, Tran B, Haskali MB, Fahey M, et al. Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [ 177 Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.269252
BibTeX
@article{Kostos2025,
author = {Kostos, Louise and Buteau, James P and Kong, Grace and Tran, Ben and Haskali, Mohammad B and Fahey, Michael and Crumbaker, Megan and Emmett, Louise and Hofman, Michael S and Azad, Arun A},
title = {Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [ 177 Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer},
journal = {Journal of Nuclear Medicine},
year = {2025},
doi = {10.2967/jnumed.124.269252}
}
EUVIMED